NDC 50102-120-00 - AUBRA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-120
- Requested NDC
- 50102-120-00
- Package NDCs from labels
- 50102-120-00, 50102-120-01, 50102-120-48, 50102-120-10, 50102-120-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AUBRA - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-120-03 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-03 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-120-00 | EA - Each | 50102-120 | d9bee6d9-aa9d-4898-93de-438dae2bb869 | 1 | 2022-06-06 |
| 50102-120-01 | EA - Each | 50102-120 | 8b796782-496f-4ed0-b025-66127b0fc3f9 | 1 | 2013-11-04 |
| 50102-120-03 | EA - Each | 50102-120 | c2265cdf-ed8f-437d-9e4b-312af0119f71 | 1 | 2017-09-11 |
| 50102-120-10 | EA - Each | 50102-120 | 5c1fb698-e254-4b92-8ed9-eb87d3604632 | 1 | 2017-09-11 |
| 50102-120-48 | EA - Each | 50102-120 | 8a66d499-33ea-4443-a859-d114a3240255 | 1 | 2013-11-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | 3108a9bc-3378-459d-8f6b-bd5eff2ad657 | 2024-01-15 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | 89948751-bd6e-4e9c-b87c-8782706c1097 | 2024-01-15 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| ZAFEMY | NORELGESTROMIN AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | 77230a20-4269-4abf-ae2a-ac5ccafef565 | 2024-01-05 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Etonogestrel/Ethinyl Estradiol | ETONOGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | fcf9da2a-bb91-4697-bfaa-c9d58855e275 | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Aurovela 1.5/30 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Aurobindo Pharma Limited | b146e49c-a0fc-4f3d-9ad6-99e8257fa139 | 2023-11-21 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| PostDay One-Step | LEVONORGESTREL | Rapha Pharmaceuticals, Inc. | 6f7f5697-acb6-ea95-e053-2991aa0ae7c7 | 2023-11-21 | Warnings | 5W7SIA7YZW |
| Aurovela 1/20 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Aurobindo Pharma Limited | 6765becf-7b51-4f33-ac13-70fcd01decf7 | 2023-11-21 | Warnings, Adverse reactions | 423D2T571U |
| Plan B One-Step | LEVONORGESTREL | A-S Medication Solutions | fcc7ba8e-ad54-4efe-87e4-5eb0fbf4f064 | 2023-10-24 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | Xiromed LLC | 626a2333-ff56-ef28-a287-b33bacc0302a | 2023-09-05 | Warnings | 5W7SIA7YZW |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | BioActive Nutritional | 3382df85-3ec5-4371-830e-4ed345b8f51b | 2023-07-14 | Warnings | 368GB5141J |
| Pneumotox | TRITICUM AESTIVUM, ALFALFA, ARNICA MONTANA, ASCLEPIAS TUBEROSA, CHAMOMILLA, ECHINACEA (ANGUSTIFOLIA), EUCALYPTUS GLOBULUS, FUCUS VESICULOSUS, HORDEUM VULGARE, IODIUM, NASTURTIUM AQUATICUM, PLANTAGO MAJOR, RAPHANUS SATIVUS, TRIFOLIUM PRATENSE, TRIGONELLA FOENUM-GRAECUM, SYMPHYTUM OFFICINALE, LUNG (SUIS), ORYZA SATIVA, SILICEA, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, NATRUM MURIATICUM, NITRICUM ACIDUM, | BioActive Nutritional, Inc. | f8846fb1-92e5-4f8e-b3b3-bc620df90a62 | 2023-07-12 | Warnings | 368GB5141J |
| LILETTA | LEVONORGESTREL | Allergan, Inc. | aaf0eb2a-f88a-4f26-a445-0fd30176c326 | 2023-06-29 | Warnings, Adverse reactions | 5W7SIA7YZW |
| Ferrum Oxydatum | FERRUM OXYDATUM | Hahnemann Laboratories, INC. | f8b52d3f-3fe2-a850-e053-6394a90a5d9f | 2023-04-06 | 1K09F3G675 | |
| Levonorgestrel | LEVONORGESTREL | Naari Pte Limited | be8b7ace-9af8-4417-85fa-863e19072887 | 2023-03-16 | Warnings | 5W7SIA7YZW |
| 09ac2d1c-97b5-4a05-af08-d58a0448c122 | efa6c9a7-ed87-4c86-ba37-534d55127755 | 2023-02-09 | Boxed warning, Warnings, Adverse reactions | efa6c9a7-ed87-4c86-ba37-534d55127755 | ||
| Next Choice One Dose | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 504735bd-6af9-4588-bf85-d09dbf2a7e41 | 2023-02-02 | Warnings | 5W7SIA7YZW |
| Take Action | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 78eee7c9-5ca5-45af-898f-92a2f3b2598e | 2023-01-31 | Warnings | 5W7SIA7YZW |
| Aftera | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 53ad8dff-9134-475c-90b3-8087753e17c4 | 2023-01-31 | Warnings | 5W7SIA7YZW |
| Plan B One-Step | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 6ce6b40e-14ac-47bd-a648-ddf9e452e559 | 2023-01-31 | Warnings | 5W7SIA7YZW |
| Opcicon One-Step | LEVONORGESTREL | Sun Pharmaceutical Industries, Inc. | b67ca313-561e-471f-baf3-257b7e253c75 | 2023-01-13 | Warnings | 5W7SIA7YZW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.